0001213900-21-027991.txt : 20210519 0001213900-21-027991.hdr.sgml : 20210519 20210519174032 ACCESSION NUMBER: 0001213900-21-027991 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210517 FILED AS OF DATE: 20210519 DATE AS OF CHANGE: 20210519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kaplan Myron CENTRAL INDEX KEY: 0001672645 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34673 FILM NUMBER: 21941466 MAIL ADDRESS: STREET 1: C/O KLEINBERG, KAPLAN, WOLFF & COHEN, PC STREET 2: 551 FIFTH AVENUE, 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10176 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CorMedix Inc. CENTRAL INDEX KEY: 0001410098 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4200 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-9500 MAIL ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4200 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 4 1 ownership.xml X0306 4 2021-05-17 0 0001410098 CorMedix Inc. CRMD 0001672645 Kaplan Myron C/O CORMEDIX INC., 300 CONNELL DRIVE, SUITE 4200 BERKELEY HEIGHTS NJ 07922 1 0 0 0 Common Stock 2021-05-17 4 P 0 15000 6.0318 A 165034 D Stock Option (Right to Buy Common Stock) 8.32 2031-01-11 Common Stock 30000 30000 D Stock Option (Right to Buy Common Stock) 5.63 2030-02-25 Common Stock 15000 15000 D Stock Option (Right to Buy Common Stock) 8.3 2029-01-10 Common Stock 15000 15000 D Stock Option (Right to Buy Common Stock) 2.85 2028-02-16 Common Stock 8000 8000 D Stock Option (Right to Buy Common Stock) 11.2 2027-02-21 Common Stock 8000 8000 D Stock Option (Right to Buy Common Stock) 21.4 2026-04-28 Common Stock 10000 10000 D This transaction was executed in multiple trades at prices ranging from $5.98 to $6.09. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. These options were granted on 1/11/2021. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. These options were granted on 01/10/2019. These options are fully vested. These options were granted on 02/16/2018. These options are fully vested. These options were granted on 02/21/2017. These options are fully vested. These options were granted on 4/28/2016. These options are fully vested. The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split. /s/ Myron Kaplan 2021-05-19